Company: BNBX
Filing Date: 2025-04-15
Form Type: DEF 14A
Source: 0001104659-25-034898
Chunk: 12

Company: BNB PLUS CORP.
Filing Date: 2025-04-15
Form: DEF 14A
Chunk 12
---
 • Proposal No. 5: to approve an amendment to the Company’s 2020 Equity Incentive Plan to increase the number of authorized shares of Common Stock reserved for issuance by three million shares; • Proposal No. 6: to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers; and • Proposal No. 7: to approve, on a non-binding advisory basis, the frequency of the stockholder vote on the compensation of the Company’s named executive officers. Each of these proposals is described in further detail below. What happens if additional matters are presented at the Annual Meeting? Other than the items of business described in this Proxy Statement, we are not currently aware of any other business to be acted upon at the Annual Meeting. If you grant a proxy, the persons named as proxy holders, Ms. Beth Jantzen and Ms. Judith Murrah, will have the discretion to vote your shares on any additional matters properly presented for a vote at the meeting. If for any reason any of the nominees is not available as a candidate for director, the persons named as proxies will vote your proxy for such other candidate or candidates as may be nominated by the Board of Directors. How does the Board of Directors recommend that I vote? As to the proposals to be voted on at the Annual Meeting, the Board of Directors unanimously recommends that you vote: 5 TABLE OF CONTENTS • FOR Proposal No. 1, for the election of each of the six nominated candidates for director; • FOR Proposal No. 2, for the ratification of the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending September 30, 2025; • FOR Proposal No. 3, to grant discretionary authority to the Board of Directors for 12 months to effect the Reverse Split Proposal; • FOR Proposal No. 4, to approve, in accordance with Nasdaq Listing Rule 5635(d), the exercisability of certain common stock purchase warrants, and the issuance of the Common Stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024; • FOR Proposal No. 5, to approve an amendment to the Company’s 2020 Equity Incentive Plan to increase the number of authorized shares of common stock reserved for issuance by three million shares; • FOR Proposal No. 6, for the approval, on a non-binding advisory basis, of the compensation